Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

Neurology

Volumn 50, Issue 5, 1998, Pages 1289-1293

  Filippi, Filippi ^a   Rocca, M A ^b   Rizzo, G ^b   Horsfield, M A ^b   Rovaris, M ^b   Minicucci, L ^b   Colombo, B ^b   Comi, G ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEMYELINATION; FEMALE; GLIOSIS; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; TISSUE INJURY;

EID: 0344653644     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.5.1289     Document Type: Article

References (32)

1. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334.
2. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann Neurol 1993;34:661-669.
3. Campi A, Filippi M, Comi G, et al. Magnetization transfer ratios of enhancing and non-enhancing lesions in multiple sclerosis. Neuroradiology 1996;38:115-119.
4. 1-weighted images. AJNR Am J Neuroradiol 1995; 16:69-77.
5. Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049.
6. Silver NC, Good CD, Barker GJ, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 1997;120:1149-1161.
7. van Waesberghe JHTM, Castelijns JA, Roser W, et al. Single dose gadolinium with magnetization transfer contrast versus triple dose gadolinium in detecting enhancing multiple sclerosis lesions. AJNR Am J Neuroradiol 1997;18:1279-1285.
8. 1-weighted images with and without magnetization transfer after the injection of standard and triple dose of gadolinium in detecting enhancing lesions in MS. J Neurol 1997;244(suppl 3):S24. Abstract.
9. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996;46: 379-384.
10. Filippi M, Rovaris M, Capra R, et al. A multicentre longitudinal study comparing the sensitivity of enhanced brain MRI after the injection of standard and triple dose gadolinium-DTPA for detecting active lesions in MS. Neurology 1997; 48(suppl):A362. Abstract.
11. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
12. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
13. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
14. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted Action Guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
15. Barkhof F, Filippi M, van Waesberghe JH, et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in MS. Neurology 1997;49:1682-1688.
16. 2-weighted images. J Neurol 1997;244:266-270.
17. Friston KJ, Ashburner J, Poline JB, Frith CD, Heather JD, Frackowiak RSJ. Spatial realignment and normalization of images. Human Brain Mapping 1995;3:165-189.
18. Filippi M, Campi A, Martinelli V, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59: 540-544.
19. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:526-530.
20. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imag ing. I. Fundamental concepts. Magn Reson Med 1991;17:357-367.
21. Dousset V, Brochet B, Gayou A, et al. Magnetization transfer profile of demyelinating CNS lesions. Proc Soc Magn Reson 1995;1:114. Abstract.
22. Lai HM, Davie CA, Gass A, et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311.
23. Filippi M, Gomi G. Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis. J Neurol Sci 1997;151:79-81.
24. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
25. van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998 (in press).
26. Prineas JW, Barnard RO, Kwon EE, et al. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993;33:137-151.
27. Lexa FJ, Grossman RI, Rosenquist AC. MR of Wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212.
28. Dousset V, Brochet B, Vital A, et al. MR imaging including diffusion and magnetization transfer of chronic relapsing ex-perimental encephalomyelitis - correlation with immunological and pathological data. Proc Soc Magn Reson 1994;1:483. Abstract.
29. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 1995;16: 225-231.
30. Thorpe JW, Barker GJ, Jones SJ, et al. Quantitative MRI in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995;59:487-492.
31. Lassman H, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994;36:S42-S46.
32. Dousset V, Grossman RI, Ramer NK, et al Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.